Showing results (151-160 of 286) with videos related to
Sort By:
Pageof 29
Neurology|December 18, 2016
Second monotherapy in childhood absence epilepsyAvital Cnaan, Shlomo Shinnar, Ravindra Arya, et al.European Journal of Cancer (Oxford, England : 1990)|November 18, 2011
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology GroupSylvain Baruchel, Alberto Pappo, Mark Krailo, et al.Pediatric Blood & Cancer|September 25, 2004
Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapyMichael J Fisher, Beverly J Lange, Michael N Needle, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 12, 2020
Characteristics of Pediatric Extracorporeal Membrane Oxygenation Programs in the United States and CanadaLindsey Troy, Felice Su, Todd Kilbaugh, et al.Pediatric Blood & Cancer|June 30, 2012
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group studyAnne B Warwick, Suman Malempati, Mark Krailo, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|October 1, 2019
A Multicenter Network Assessment of Three Inflammation Phenotypes in Pediatric Sepsis-Induced Multiple Organ FailureJoseph A Carcillo, Robert A Berg, David Wessel, et al.Shock (Augusta, Ga.)|September 3, 2024
IMPACT OF ABCC8 AND TRPM4 GENETIC VARIATION IN CENTRAL NERVOUS SYSTEM DYSFUNCTION ASSOCIATED WITH PEDIATRIC SEPSISKate F Kernan, Ashley Adkins, Ruchira M Jha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium reportStacey L Berg, Mitchell S Cairo, Heidi Russell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group StudySusan R Rheingold, Michael D Hogarty, Susan M Blaney, et al.The New England Journal of Medicine|March 5, 2010
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsyTracy A Glauser, Avital Cnaan, Shlomo Shinnar, et al.Pageof 29